PARIS – Beiersdorf AG said Tuesday that it is investing in a startup for digital dermatological appointments, called Dermanosotic.
The maker of Nivea, Eucerin and La Prairie products is taking an undisclosed stake in the Düsseldorf, Germany-based startup through its Oscar&Paul Beiersdorf Venture Capital unit.
More from WWD
Teledermatology is a growing space, especially during the coronavirus pandemic, making derm-related apps with advisory services alluring to investors.
The way Dermanostic works is that people can book a service seven days a week, 24 hours a day, for 25 euros, no matter where they are located. A diagnosis by an experienced dermatologist is given within 24 hours after someone has uploaded three photographs and filled out a questionnaire about their medical history.
Especially in less serious cases, such a service can provide quick solutions for a skin-care problem, with a prescription being sent by mail or email to online pharmacists.
People can find information on the offers and services through www.eucerin.de, as well as www.dermanostic.com.
“We believe digital health and teledermatology offer huge potential, especially among the younger target group,” Ascan Voswinckel, head of Oscar&Paul Beiersdorf Venture Capital said in a statement. “Digital dermatologist appointments offer our customers significant added value as they allow for swift, straightforward, inexpensive and professional advice regarding their skin indication. As such, Dermanostic’s new digital service is the perfect fit for our Eucerin brand and innovatively complements our dermocosmetic brand’s digital consumer journey.”
“The collaboration with Dermanostic is a relevant aspect of our digitalization strategy,” said Cornelius Becker, head of Derma at Beiersdorf. “Especially in these times of COVID-19 and physical distancing, we must find digital ways of offering our consumers the right advice to solve their skin problems. By engaging in close communication with the experts at Dermanostic, we can learn from one another and thus do even better at establishing digital closeness with our consumers.”
Becker added that the tie-in underlines Beiersdorf’s believe in the “life-changing power of dermatological skin care.”
The Oscar&Paul Beiersdorf Venture Capital branch is focused on innovative companies and start-ups with forward-facing technologies, new business models and skin-care innovations. In May 2021, it invested in personalized skin-care brand Routinely.
Another German dermatology-related platform, Formel Skin, in late December said it had secured a 30-million-euro Series A funding, led by Paris-based venture capital firm Singular and German HealthTech investor Heal Capital.
That brought the company’s total funding to 36 million euros in investor funding, making Formel Skin among the fastest-growing health tech companies in Europe.
For more, see: